|
1
|
Karsa LV, Lignini TA, Patnick J, Lambert R
and Sauvaget C: The dimensions of the CRC problem. Best Pract Res
Clin Gastroenterol. 24:381–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kriza C, Emmert M, Wahlster P,
Niederländer C and Kolominsky-Rabas P: Cost of illness in
colorectal cancer: An international review. Pharmacoeconomics.
31:577–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berg M and Søreide K: Genetic and
epigenetic traits as biomarkers in colorectal cancer. Int J Mol
Sci. 12:9426–9439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pritchard CC and Grady WM: Colorectal
cancer molecular biology moves into clinical practice. Gut.
60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giguère V: Transcriptional control of
energy homeostasis by the estrogen-related receptors. Endocr Rev.
29:677–696. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horard B and Vanacker JM: Estrogen
receptor-related receptors: Orphan receptors desperately seeking a
ligand. J Mol Endocrinol. 31:349–357. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cavallini A, Notarnicola M, Giannini R,
Montemurro S, Lorusso D, Visconti A, Minervini F and Caruso MG:
Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen
receptors (ERalpha and ERbeta) exhibit different gene expression in
human colorectal tumour progression. Eur J Cancer. 41:1487–1494.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bosman FT, Carneiro F, Hruban R and Theise
N: WHO Classification of Tumours of the Digestive System. 3. 4th.
IARC; Lyon: 2010
|
|
11
|
Sarma DP: The Dukes classification of
colorectal cancer. JAMA. 256:14471986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rudolph A, Toth C, Hoffmeister M, Roth W,
Herpel E, Jansen L, Marx A, Brenner H and Chang-Claude J:
Expression of oestrogen receptor β and prognosis of colorectal
cancer. Br J Cancer. 107:831–839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deblois G, St-Pierre J and Giguère V: The
PGC-1/ERR signaling axis in cancer. Oncogene. 32:3483–3490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bianco S, Sailland J and Vanacker JM: ERRs
and cancers: Effects on metabolism and on proliferation and
migration capacities. J Steroid Biochem Mol Biol. 130:180–185.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang JW, Guan BZ, Yin LH, Liu FN, Hu B,
Zheng QY, Li FL, Zhong YX and Chen Y: Effects of estrogen-related
receptor alpha (ERRα) on proliferation and metastasis of human lung
cancer A549 cells. J Huazhong Univ Sci Technolog Med Sci.
34:875–881. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen P, Wang H, Duan Z, Zou JX, Chen H, He
W and Wang J: Estrogen-related receptor alpha confers methotrexate
resistance via attenuation of reactive oxygen species production
and P53 mediated apoptosis in osteosarcoma cells. Biomed Res Int.
2014:6160252014.PubMed/NCBI
|
|
18
|
Sun P, Sehouli J, Denkert C, Mustea A,
Könsgen D, Koch I, Wei L and Lichtenegger W: Expression of estrogen
receptor-related receptors, a subfamily of orphan nuclear
receptors, as new tumor biomarkers in ovarian cancer cells. J Mol
Med (Berl). 83:457–467. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujimoto J, Alam SM, Jahan I, Sato E,
Sakaguchi H and Tamaya T: Clinical implication of estrogen-related
receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol
Biol. 104:301–314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao M, Sun P, Wang J, Zhao D and Wei L:
Expression of estrogen receptor-related receptor isoforms and
clinical significance in endometrial adenocarcinoma. Int J Gynecol
Cancer. 16:827–833. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujimura T, Takahashi S, Urano T, Kumagai
J, Ogushi T, Horie-Inoue K, Ouchi Y, Kitamura T, Muramatsu M and
Inoue S: Increased expression of estrogen-related receptor alpha
(ERRalpha) is a negative prognostic predictor in human prostate
cancer. Int J Cancer. 120:2325–2330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suzuki T, Miki Y, Moriya T, Shimada N,
Ishida T, Hirakawa H, Ohuchi N and Sasano H: Estrogen-related
receptor alpha in human breast carcinoma as a potent prognostic
factor. Cancer Res. 64:4670–4676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bernatchez G, Giroux V, Lassalle T,
Carpentier AC, Rivard N and Carrier JC: ERRα metabolic nuclear
receptor controls growth of colon cancer cells. Carcinogenesis.
34:2253–2261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y
and He F: miR-137 targets estrogen-related receptor alpha and
impairs the proliferative and migratory capacity of breast cancer
cells. PLoS One. 7:e391022012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tiwari A, Shivananda S, Gopinath KS and
Kumar A: MicroRNA-125a reduces proliferation and invasion of oral
squamous cell carcinoma cells by targeting estrogen-related
receptor α: Implications for cancer therapeutics. J Biol Chem.
289:32276–32290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Todosi AM, Gavrilescu MM, Aniţei GM, Filip
B and Scripcariu V: Colon cancer at the molecular level-usefulness
of epithelial-mesenchymal transition analysis. Rev Med Chir Soc Med
Nat Iasi. 116:1106–1111. 2012.PubMed/NCBI
|
|
27
|
Lam SS, Mak AS, Yam JW, Cheung AN, Ngan HY
and Wong AS: Targeting estrogen-related receptor alpha inhibits
epithelial-to-mesenchymal transition and stem cell properties of
ovarian cancer cells. Mol Ther. 22:743–751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boudjadi S, Bernatchez G, Beaulieu JF and
Carrier JC: Control of the human osteopontin promoter by ERRα in
colorectal cancer. Am J Pathol. 183:266–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pietras A, Katz AM, Ekström EJ, Wee B,
Halliday JJ, Pitter KL, Werbeck JL, Amankulor NM, Huse JT and
Holland EC: Osteopontin-CD44 signaling in the glioma perivascular
niche enhances cancer stem cell phenotypes and promotes aggressive
tumor growth. Cell Stem Cell. 14:357–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao L, Fan X, Jing W, Liang Y, Chen R, Liu
Y, Zhu M, Jia R, Wang H, Zhang X, et al: Osteopontin promotes a
cancer stem cell-like phenotype in hepatocellular carcinoma cells
via an integrin-NF-κB-HIF-1α pathway. Oncotarget. 6:6627–6640.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rao G, Wang H, Li B, Huang L, Xue D, Wang
X, Jin H, Wang J, Zhu Y, Lu Y, et al: Reciprocal interactions
between tumor-associated macrophages and CD44-positive cancer cells
via osteopontin/CD44 promote tumorigenicity in colorectal cancer.
Clin Cancer Res. 19:785–797. 2013. View Article : Google Scholar : PubMed/NCBI
|
